Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

One-Quarter of Biologic Drugs Have Had Safety Issues


Related Encyclopedia
 border=
Abdominoplasty
Acidophilus
Adhesions
Amebiasis
More...

Related Healthscout Videos
 border=
Hungry Heart
Joint Attack
Heavy Weight Battle
Nutrition and Cancer
More...

Related Animations
 border=
GERD
PPI Therapy
Rheumatoid Arthritis
More...

Related Drug Information
 border=
Aciphex
Klor-Con
Klor-Con ER
Nexium
More...

Related News Articles
 border=
Vitamin D Good for Breast Cancer Patients
Exercise Boosts Bone Density in Breast-Feeding Moms
Nutrition Still Not 'A' Grade in U.S. Schools: Studies
Health Tip: Why Do I Get Muscle Cramps?
More...


Page:  << Prev | 1 | 2

Although all drugs carry risks, biologics are in a special class, because they are derived from biological sources, including antibodies, enzymes and hormones.

Enbrel (etanercept), for instance, is a tumor necrosis factor, a protein made by the body's immune system. The drug, used to treat various forms of arthritis as well as psoriasis, was also the recipient of a black box warning (for infections and central nervous system disorders).

The authors of this paper, from Utrecht University, reviewed 174 biologics approved in the United States and/or the European Union between January 1995 and June 2007.

Text Continues Below



Between January 1995 and June 2008, 82 safety-related regulatory actions were issued for 41 of the medications, or almost 24 percent of the total.

Of these 82 actions, 63 were advisory letters to health-care professionals in the United States and Europe, and 19 were black box warnings. None of the drugs were withdrawn from the market.

Most of the actions (70.7 percent) were taken within the first five years after approval, with 3.7 years being the average time until a regulatory action was issued.

By way of comparison, a 2002 paper in JAMA showed that, of 548 new non-biologic drugs approved over a 25-year span, 1975-2000, 10 percent had new black box warnings or were withdrawn from the market and about half of those warnings or withdrawals occurred within two years after the product had been on the market.

Biologic medications that were the first to be developed in their class were more likely to have safety-related actions, compared to later contenders, the new study found.

"Patients who are on these medications must be appropriately selected to receive them and monitored appropriately," Saubermann said. "We have to screen appropriately before the drugs are started, make sure the patient hasn't tried other options, then follow up."

More information

Visit the U.S. Food and Drug Administration for more on these drugs.

Page:  << Prev | 1 | 2

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 10/21/2008

Related Links
 border=
From Healthscout's partner site on rheumatoid arthritis, MyRACentral.com
Do you know about rheumatoid arthritis symptoms?
Rheumatoid arthritis and diet - Are they related?
Want to know about treatment for rheumatoid arthritis?





SOURCES: Lisa Saubermann, Pharm.D., associate director, clinical pharmacy services, University of Rochester Medical Center, New York; Phil B. Fontanarosa, M.D., executive deputy editor, Journal of the American Medical Association; Oct. 22/29, 2008, Journal of the American Medical Association


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy